Covered recipient · General Payments record
DANIELLE MARIE SPALLIN
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$1,770.12
- Reported across 81 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $266.23 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $52.03 | 3 |
| Organon LLC | $48.48 | 2 |
| Sumitomo Pharma America, Inc. | $34.16 | 2 |
| Exeltis, USA Inc. | $29.77 | 2 |
| BECTON, DICKINSON AND COMPANY | $19.34 | 1 |
| ConvaTec Inc. | $17.82 | 1 |
| Merck Sharp & Dohme Corporation | $17.15 | 1 |
| PFIZER INC. | $16.81 | 1 |
| Biogen, Inc. | $15.90 | 1 |
| MILLICENT US INC | $14.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $13.74 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139286332 | CMS |
| Astellas Pharma US Inc | $19.60 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139369061 | CMS |
| Astellas Pharma US Inc | $18.69 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139357721 | CMS |
| Becton, Dickinson and Company | $19.34 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127613362 | CMS |
| Biogen, Inc. | $15.90 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104844636 | CMS |
| ConvaTec Inc. | $17.82 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151385473 | CMS |
| Exeltis, USA Inc. | $14.15 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150005130 | CMS |
| Exeltis, USA Inc. | $15.62 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150005132 | CMS |
| Merck Sharp & Dohme LLC | $17.15 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141739907 | CMS |
| MILLICENT US INC | $14.77 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150912296 | CMS |
| Organon Llc | $27.94 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136301102 | CMS |
| Organon Llc | $20.54 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136301104 | CMS |
| PFIZER INC. | $16.81 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131826625 | CMS |
| Sumitomo Pharma America, Inc. | $15.32 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148922593 | CMS |
| Sumitomo Pharma America, Inc. | $18.84 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148922595 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.